Paper published in a journal (Scientific congresses and symposiums)
A single infusion of zoledronic acid 5 mg (ZOL) is significantly more effective than daily oral risedronate 5 mg (RIS) in increasing bone mineral density (BMD) of the lumbar spine (LS), hip, femoral neck and trochanter in patients with glucocorticoid-induced osteoporosis (GIO)
Reid, D. M.; Devogelaer, Jean-Pierre; Saag, K.et al.
2008 • In Osteoporosis International, 19 (Suppl.1), p. 23-24
Endocrinology, metabolism & nutrition General & internal medicine Public health, health care sciences & services
Author, co-author :
Reid, D. M.
Devogelaer, Jean-Pierre
Saag, K.
Roux, Christian
Lau, C. S.
Reginster, Jean-Yves ; Université de Liège - ULiège > Département des sciences de la santé publique > Santé publique, Epidémiologie et Economie de la santé
Papanastasiou, P.
Ferreira, A.
Fashola, T.
Sambrook, P.
Language :
English
Title :
A single infusion of zoledronic acid 5 mg (ZOL) is significantly more effective than daily oral risedronate 5 mg (RIS) in increasing bone mineral density (BMD) of the lumbar spine (LS), hip, femoral neck and trochanter in patients with glucocorticoid-induced osteoporosis (GIO)
Publication date :
April 2008
Event name :
Eight European Congress on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis
Event organizer :
WHO Collaborating Center for Public Health Aspects of Osteoarticular Disorders, Liège, Belgium and ESCEO
Event place :
Istanbul, Turkey
Event date :
du 9 avril 2008 au 12 avril 2008
Audience :
International
Journal title :
Osteoporosis International
ISSN :
0937-941X
eISSN :
1433-2965
Publisher :
Springer Science & Business Media B.V., Godalming, United Kingdom
